Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.43623 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.35192 | 14 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.35761 | 14 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.29965 | 14 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.30065 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.42369 | 15 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.40117 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.33503 | 14 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.32455 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.34638 | 14 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.34538 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.32796 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.35232 | 14 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.3501 | 14 |